Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Bone Marrow Transplant
•
AML
What transplant conditioning regimen would you recommend for a pediatric patient with MDS and monosomy 7?
Related Questions
In what situations do you use G-CSF for patients undergoing allogeneic HSCT to facilitate engraftment?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
How do you decide between HSCT and immunosuppressive therapy for treating hepatitis associated aplastic anemia?
Are there instances where you would use C5 complement inhibitors for isolated elevation of sc5b-9 in the absence of other TA-TMA features?
How do you approach autologous stem cell transplant in T-cell lymphomas/PTCL after induction chemotherapy with achievement of CR1?
What therapy would you consider for refractory pediatric HR AML with KMT2Ar to try to induce remission for transplant?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Based on the FIREFLY-1 data, would you consider using tovorafenib monotherapy front-line in pediatric patients who have low grade gliomas that are only amenable to subtotal resection or are unresectable?
Would you consider combining tovorafenib and trametinib as dual therapy?
What workup do you consider for a developmentally typical child with multiple large café au lait macules but no other signs of neurofibromatosis?
